# TNONW (Tenon Medical, Inc.) - SEC EDGAR Financial Statements

> Tenon Medical, Inc. reported $5.57M in revenue and a net loss of $17.00M for the trailing twelve months ended September 30, 2026 (up 22.1% year over year), with a 66.9% gross margin and a -225.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/TNONW
- Markdown: https://convexityos.com/fundamentals/TNONW.md
- SEC CIK: 0001560293
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001560293&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.57M | +22.1% YoY |
| Operating Income | TTM | -$12.59M | -225.9% margin |
| Net Income | TTM | -$17.00M | -305.1% net margin |
| Diluted EPS | TTM | -$13,807.47 | Split-adjusted |
| Free Cash Flow | TTM | -$11.02M | -197.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $8.27M | Total debt: $1.29M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $3.94M | $3.28M | $2.25M | $691K | $160K |
| Cost of Revenue | $1.59M | $1.57M | $1.69M | $1.33M | $55K |
| **Gross Profit** | $2.36M | $1.71M | $1.24M | -$641K | $105K |
| Research & Development | $2.15M | $2.60M | $3.16M | $2.83M | $1.72M |
| Selling, General & Admin | $13.00M | $12.87M | $13.80M | $15.26M | $4.85M |
| Total Operating Expenses | $15.15M | $15.48M | $16.97M | $18.08M | $6.57M |
| **Operating Income** | -$12.79M | -$13.77M | -$15.73M | -$18.73M | -$6.46M |
| **EBITDA** | -$12.53M | -$13.36M | -$15.53M | -$18.65M | -$6.46M |
| Interest Expense | -- | $34K | $21K | $354K | $621K |
| Income Before Tax | -- | -- | -- | -$18.92M | -$7.08M |
| **Net Income** | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.05M |
| Basic EPS | -$59.65 | -$395.09 | -$2,408.42 | -$6,630.18 | -$21,922.81 |
| **Diluted EPS** | -$59.65 | -$395.09 | -$2,408.42 | -$6,630.18 | -$21,922.81 |
| Basic Shares Outstanding | 210 | 35 | 6 | 3 | 0 |
| Diluted Shares Outstanding | 210 | 35 | 6 | 3 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.43M | $1.28M | $1.38M | $1.48M | $1.17M | $564K | $726K | $770K |
| Cost of Revenue | $482K | $465K | $434K | $464K | $400K | $319K | $403K | $417K |
| **Gross Profit** | $950K | $814K | $945K | $1.02M | $773K | $245K | $323K | $353K |
| Research & Development | $804K | $768K | $662K | $527K | $428K | $503K | $691K | $569K |
| Selling, General & Admin | $3.23M | $3.40M | $3.56M | $3.36M | $3.74M | $2.60M | $3.31M | $2.96M |
| Total Operating Expenses | $4.04M | $4.17M | $4.22M | $3.88M | $4.17M | $3.10M | $4.00M | $3.53M |
| **Operating Income** | -$3.08M | -$3.35M | -$3.28M | -$2.87M | -$3.39M | -$2.86M | -$3.68M | -$3.17M |
| **EBITDA** | -$3.01M | -$3.29M | -$3.19M | -$2.77M | -$3.31M | -$2.81M | -$3.63M | -$3.06M |
| Interest Expense | $719K | $852K | $176K | -- | -- | -- | -- | $0 |
| **Net Income** | -$6.64M | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | -$3.62M | -$3.09M |
| Basic EPS | -$5.39 | -$12.35 | -$10.88 | -- | -$14.17 | -$12.76 | -$35.44 | -- |
| **Diluted EPS** | -$5.39 | -$12.35 | $10.88 | -- | -$14.17 | -$12.76 | $35.44 | -- |
| Basic Shares Outstanding | 1.2K | 328 | 321 | -- | 236 | 217 | 103 | -- |
| Diluted Shares Outstanding | 1.2K | 328 | 321 | -- | 236 | 217 | 103 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.76M | $6.54M | $2.43M | $2.13M | $2.92M |
| Short-Term Investments | -- | -- | -- | $6.44M | $4.40M |
| **Cash & Short-Term Investments** | $3.76M | $6.54M | $2.43M | $8.57M | $7.32M |
| Accounts Receivable, Net | $1.70M | $863K | $518K | $228K | $76K |
| Inventory | $1.05M | $606K | $554K | $415K | $188K |
| **Total Current Assets** | $6.77M | $8.21M | $3.89M | $9.35M | $7.67M |
| Property, Plant & Equipment, Net | $918K | $752K | $961K | $793K | $101K |
| Goodwill | $2.41M | -- | -- | -- | -- |
| Intangible Assets | $485K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $3.99M | $1.63M | $2.46M | $1.74M | $1.60M |
| **Total Assets** | $10.76M | $9.84M | $6.34M | $11.09M | $9.27M |
| Accounts Payable | $845K | $369K | $433K | $550K | $478K |
| **Total Current Liabilities** | $3.21M | $1.87M | $3.14M | $2.53M | $15.27M |
| **Total Non-Current Liabilities** | $2.51M | $2.00M | $2.43M | $2.31M | $911K |
| **Total Liabilities** | $5.72M | $3.87M | $5.57M | $4.84M | $16.18M |
| **Total Debt (incl. Leases)** | $141K | $428K | $684K | $911K | $1.11M |
| Common Stock | $11K | $3.0K | $3.0K | $1.0K | $1.0K |
| Retained Earnings | -$81.30M | -$68.75M | -$55.07M | -$39.49M | -$20.57M |
| Accumulated Other Comp. Income | -- | -- | -$46K | -$100K | -$91K |
| **Total Stockholders' Equity** | $5.04M | $5.97M | $778K | $6.25M | -$20.55M |
| Total Equity | $5.04M | $5.97M | $778K | $6.25M | -$20.55M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.27M | $1.68M | $4.61M | $3.76M | $3.44M | $7.85M | $10.31M | $6.54M |
| **Cash & Short-Term Investments** | $8.27M | $1.68M | $4.61M | $3.76M | $3.44M | $7.85M | $10.31M | $6.54M |
| Accounts Receivable, Net | $1.70M | $1.95M | $1.97M | $1.70M | $1.31M | $770K | $886K | $863K |
| Inventory | $882K | $783K | $806K | $1.05M | $1.36M | $688K | $607K | $606K |
| **Total Current Assets** | $11.22M | $4.81M | $7.62M | $6.77M | $6.54M | $9.88M | $11.99M | $8.21M |
| Property, Plant & Equipment, Net | $717K | $771K | $901K | $918K | $663K | $842K | $698K | $752K |
| Goodwill | $2.41M | $2.41M | $2.41M | $2.41M | $2.41M | -- | -- | -- |
| Intangible Assets | $441K | $455K | $470K | $485K | $500K | -- | -- | -- |
| **Total Non-Current Assets** | $4.98M | $5.12M | $5.22M | $3.99M | $3.82M | $1.23M | $1.40M | $1.63M |
| **Total Assets** | $16.20M | $9.92M | $12.84M | $10.76M | $10.37M | $11.11M | $13.39M | $9.84M |
| Accounts Payable | $657K | $628K | $646K | $845K | $625K | $894K | $496K | $369K |
| **Total Current Liabilities** | $3.83M | $8.30M | $7.41M | $3.21M | $3.04M | $2.56M | $2.19M | $1.87M |
| **Total Non-Current Liabilities** | $3.15M | $3.36M | $3.54M | $2.51M | $2.53M | $1.84M | $1.82M | $2.00M |
| **Total Liabilities** | $6.98M | $11.66M | $10.94M | $5.72M | $5.57M | $4.40M | $4.02M | $3.87M |
| **Total Debt (incl. Leases)** | $1.29M | $1.35M | $1.40M | $141K | $216K | $290K | $360K | $428K |
| Common Stock | $3.0K | -- | $11K | $11K | $9.0K | $8.0K | $8.0K | $3.0K |
| Retained Earnings | -$95.47M | -$88.83M | -$84.78M | -$81.30M | -$78.47M | -$75.13M | -$72.36M | -$68.75M |
| **Total Stockholders' Equity** | $9.22M | -$1.74M | $1.90M | $5.04M | $4.80M | $6.71M | $9.38M | $5.97M |
| Total Equity | $9.22M | -$1.74M | $1.90M | $5.04M | $4.80M | $6.71M | $9.38M | $5.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.08M |
| Depreciation & Amortization | $262K | $408K | $199K | $78K | $2.0K |
| Stock-Based Compensation | $1.69M | $3.85M | $4.14M | $2.90M | $377K |
| Change in Receivables | -$851K | -$386K | -$290K | -$152K | -$61K |
| Change in Inventory | -$387K | -$52K | -$139K | -$227K | -$145K |
| Change in Payables | $486K | -$64K | -$117K | $72K | $444K |
| **Operating Cash Flow** | -$10.74M | -$9.88M | -$12.18M | -$12.03M | -$4.29M |
| Capital Expenditure | -$273K | -$186K | -$361K | -$847K | -$102K |
| **Free Cash Flow** | -$11.02M | -$10.06M | -$12.54M | -$12.87M | -$4.39M |
| Purchases of Investments | -- | -- | -- | -$10.12M | -$4.40M |
| Sales & Maturities of Investments | -- | -- | -- | $8.08M | $0 |
| **Investing Cash Flow** | -$1.02M | -$186K | $6.14M | -$2.88M | -$4.50M |
| Common Stock Issued | -- | $2.11M | $495K | $14.14M | $0 |
| **Financing Cash Flow** | $8.99M | $14.12M | $6.30M | $14.11M | $11.47M |
| **Net Change in Cash** | -$2.78M | $4.11M | $299K | -$788K | $2.67M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.64M | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | -$3.62M | -$3.09M |
| Depreciation & Amortization | $76K | $60K | $88K | $95K | $77K | $48K | $42K | $117K |
| Stock-Based Compensation | $120K | $412K | $331K | $344K | $58K | $417K | $872K | $883K |
| Change in Receivables | $249K | $27K | -$282K | -$403K | -$541K | $116K | -$23K | $18K |
| Change in Inventory | -$99K | $280K | $248K | $167K | -$484K | -$81K | $11K | $1.0K |
| Change in Payables | $29K | -$18K | -$199K | $220K | -$259K | $398K | $127K | -$724K |
| **Operating Cash Flow** | -$2.39M | -$2.76M | -$2.96M | -$2.22M | -$3.82M | -$2.21M | -$2.48M | -$2.78M |
| Capital Expenditure | -$8.0K | -$172K | -$56K | -- | -- | -- | -- | $37K |
| **Free Cash Flow** | -$2.40M | -$2.93M | -$3.02M | -- | -- | -- | -- | -$2.74M |
| **Investing Cash Flow** | -$8.0K | -$172K | -$56K | -- | -- | -- | -- | $37K |
| Common Stock Issued | -- | -- | -- | -- | -- | $0 | $4.01M | -$57K |
| **Financing Cash Flow** | $8.99M | $0 | $3.87M | $2.73M | $59K | -$59K | $6.26M | $113K |
| **Net Change in Cash** | $6.59M | -$2.93M | $851K | $314K | -$4.40M | -$2.46M | $3.78M | -$2.63M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 59.8% | 52.2% | 55.2% | -92.8% | 65.6% |
| **Operating Margin** | -324.3% | -420.1% | -699.0% | -2709.8% | -4038.1% |
| **Net Profit Margin** | -318.4% | -417.2% | -692.5% | -2737.6% | -4405.0% |
| Return on Equity (ROE) | -249.1% | -229.0% | -2002.7% | -302.6% | -- |
| Return on Assets (ROA) | -116.7% | -138.9% | -245.6% | -170.6% | -76.0% |
| Current Ratio | 2.11x | 4.39x | 1.24x | 3.69x | 0.50x |
| Quick Ratio | 1.78x | 4.07x | 1.06x | 3.53x | 0.49x |
| Debt to Equity | 0.03x | 0.07x | 0.88x | 0.15x | -- |
| **Revenue Growth (YoY)** | +20.4% | +45.6% | +225.6% | +331.9% | -- |
| Gross Profit Growth (YoY) | +37.8% | +37.9% | -- | -710.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 66.9% | 66.8% | 64.8% | 59.8% | 52.4% | 45.4% | 47.6% | 52.2% |
| **Operating Margin** | -225.9% | -242.7% | -269.6% | -324.3% | -405.2% | -438.5% | -424.4% | -420.1% |
| **Net Profit Margin** | -305.1% | -257.9% | -270.1% | -318.4% | -396.3% | -429.5% | -417.6% | -417.2% |
| Return on Equity (ROE) | -184.4% | -- | -655.2% | -249.1% | -267.0% | -188.5% | -146.3% | -229.0% |
| Return on Assets (ROA) | -104.9% | -138.0% | -96.7% | -116.7% | -123.6% | -113.9% | -102.4% | -138.9% |
| Current Ratio | 2.93x | 0.58x | 1.03x | 2.11x | 2.15x | 3.86x | 5.46x | 4.39x |
| Quick Ratio | 2.70x | 0.48x | 0.92x | 1.78x | 1.70x | 3.59x | 5.19x | 4.07x |
| Debt to Equity | 0.14x | -- | 0.74x | 0.03x | 0.05x | 0.04x | 0.04x | 0.07x |
| **Revenue Growth (YoY)** | +22.1% | +126.8% | +89.9% | +92.3% | +32.2% | -37.4% | +1.0% | -4.7% |
| Gross Profit Growth (YoY) | +22.9% | +232.2% | +192.6% | +188.1% | +84.9% | -47.9% | -31.3% | -36.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
